1. Home
  2. HUM vs KVUE Comparison

HUM vs KVUE Comparison

Compare HUM & KVUE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • HUM
  • KVUE
  • Stock Information
  • Founded
  • HUM 1961
  • KVUE 2022
  • Country
  • HUM United States
  • KVUE United States
  • Employees
  • HUM N/A
  • KVUE N/A
  • Industry
  • HUM Medical Specialities
  • KVUE Specialty Chemicals
  • Sector
  • HUM Health Care
  • KVUE Consumer Discretionary
  • Exchange
  • HUM Nasdaq
  • KVUE Nasdaq
  • Market Cap
  • HUM 35.0B
  • KVUE 39.9B
  • IPO Year
  • HUM 1993
  • KVUE 2023
  • Fundamental
  • Price
  • HUM $292.67
  • KVUE $14.31
  • Analyst Decision
  • HUM Buy
  • KVUE Buy
  • Analyst Count
  • HUM 17
  • KVUE 13
  • Target Price
  • HUM $294.19
  • KVUE $20.23
  • AVG Volume (30 Days)
  • HUM 1.9M
  • KVUE 30.8M
  • Earning Date
  • HUM 11-05-2025
  • KVUE 11-06-2025
  • Dividend Yield
  • HUM 1.21%
  • KVUE 5.80%
  • EPS Growth
  • HUM N/A
  • KVUE 28.77
  • EPS
  • HUM 13.04
  • KVUE 0.74
  • Revenue
  • HUM $123,110,000,000.00
  • KVUE $15,141,000,000.00
  • Revenue This Year
  • HUM $9.85
  • KVUE N/A
  • Revenue Next Year
  • HUM $5.48
  • KVUE $3.10
  • P/E Ratio
  • HUM $22.44
  • KVUE $19.34
  • Revenue Growth
  • HUM 9.88
  • KVUE N/A
  • 52 Week Low
  • HUM $206.87
  • KVUE $14.05
  • 52 Week High
  • HUM $315.35
  • KVUE $25.17
  • Technical
  • Relative Strength Index (RSI)
  • HUM 57.98
  • KVUE 31.59
  • Support Level
  • HUM $288.01
  • KVUE $14.81
  • Resistance Level
  • HUM $299.68
  • KVUE $15.33
  • Average True Range (ATR)
  • HUM 8.73
  • KVUE 0.68
  • MACD
  • HUM 1.82
  • KVUE 0.03
  • Stochastic Oscillator
  • HUM 83.69
  • KVUE 8.33

About HUM Humana Inc.

Humana is one of the largest private health insurers in the US, and the firm has built a niche specializing in government-sponsored programs, with nearly all its medical membership stemming from Medicare, Medicaid, and the military's Tricare program. Beyond medical insurance, the company provides other healthcare services, including primary-care services, at-home services, and pharmacy benefit management.

About KVUE Kenvue Inc.

Kenvue is the world's largest pure-play consumer health company by sales, generating over $15 billion in annual revenue. Formerly known as Johnson & Johnson's consumer segment, Kenvue spun off and went public in May 2023. It operates in a variety of silos within consumer health, such as cough, cold and allergy care, pain management, face and body care, and oral care, as well as women's health. Its portfolio has some of the most well-known brands in the space, including Tylenol, Listerine, Johnson's, Aveeno, and Neutrogena. Despite playing in a fragmented industry with intense competition and changing consumer preferences, many of Kenvue's brands are the global leader in their respective segment thanks to their strong brand power.

Share on Social Networks: